Geode Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Buy |
|
|||||
|
2025
Q1 | $7.69M | Buy |
|
|||||
|
2024
Q4 | $9.17M | Buy |
|
|||||
|
2024
Q3 | $7.75M | Buy |
|
|||||
|
2024
Q2 | $7.61M | Buy |
|
|||||
|
2024
Q1 | $19.3M | Buy |
|
|||||
|
2023
Q4 | $15.8M | Buy |
|
|||||
|
2023
Q3 | $14M | Buy |
|
|||||
|
2023
Q2 | $17.9M | Buy |
|
|||||
|
2023
Q1 | $12.8M | Buy |
|
|||||
|
2022
Q4 | $16.4M | Buy |
|
|||||
|
2022
Q3 | $26.9M | Buy |
|
|||||
|
2022
Q2 | $7.14M | Buy |
|
|||||
|
2022
Q1 | $9.73M | Buy |
|
|||||
|
2021
Q4 | $10.7M | Buy |
|
|||||
|
2021
Q3 | $12.9M | Buy |
|
|||||
|
2021
Q2 | $1.93M | Buy |
|